Labcorp Holdings Inc. financial data

Symbol
LH on NYSE
Industry
Services-Medical Laboratories
Location
358 S Main St, Burlington, NC
Fiscal year end
December 31
Former names
LABORATORY CORP OF AMERICA HOLDINGS (to 5/16/2024), NATIONAL HEALTH LABORATORIES HOLDINGS INC (to 2/13/1995)
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 114 % -27.5%
Quick Ratio 12.8 % -24.6%
Debt-to-equity 118 % +12.5%
Return On Equity 9.27 % +93.4%
Return On Assets 4.25 % +81.7%
Operating Margin 8.35 % +40.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.7M shares -0.7%
Common Stock, Shares, Outstanding 83.4M shares -0.6%
Entity Public Float 16.4B USD -5.2%
Common Stock, Value, Issued 7.6M USD -1.3%
Weighted Average Number of Shares Outstanding, Basic 83.9M shares -3.67%
Weighted Average Number of Shares Outstanding, Diluted 84.4M shares -3.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13B USD +6.97%
Cost of Revenue 9.38B USD +6.68%
Operating Income (Loss) 1.09B USD +49.8%
Income Tax Expense (Benefit) 212M USD +12.7%
Net Income (Loss) Attributable to Parent 746M USD +78.5%
Earnings Per Share, Basic 8.89 USD/shares +85.2%
Earnings Per Share, Diluted 8.84 USD/shares +85.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.52B USD +183%
Accounts Receivable, after Allowance for Credit Loss, Current 1.94B USD +1.61%
Inventory, Net 493M USD +3.92%
Assets, Current 4.81B USD +27.6%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.05B USD +4.59%
Operating Lease, Right-of-Use Asset 785M USD +6.43%
Intangible Assets, Net (Excluding Goodwill) 3.49B USD +4.4%
Goodwill 6.37B USD +3.7%
Other Assets, Noncurrent 652M USD +21.6%
Assets 18.4B USD +9.89%
Accounts Payable, Current 876M USD +5.84%
Employee-related Liabilities, Current 495M USD +14.8%
Accrued Liabilities, Current 871M USD +8.36%
Liabilities, Current 3.33B USD +3.26%
Operating Lease, Liability, Noncurrent 676M USD +4.22%
Other Liabilities, Noncurrent 517M USD +26.4%
Liabilities 10.3B USD +16.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -262M USD -341%
Retained Earnings (Accumulated Deficit) 8.3B USD +5.26%
Stockholders' Equity Attributable to Parent 8.05B USD +2.25%
Liabilities and Equity 18.4B USD +9.89%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.8M USD -125%
Net Cash Provided by (Used in) Financing Activities -11.7M USD +80.7%
Net Cash Provided by (Used in) Investing Activities -393M USD -294%
Common Stock, Shares Authorized 265M shares 0%
Common Stock, Shares, Issued 83.9M shares -4.88%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -438M USD -1112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.93B USD +97.3%
Deferred Tax Assets, Valuation Allowance 127M USD -15.3%
Deferred Tax Assets, Gross 840M USD +5.65%
Operating Lease, Liability 861M USD +5.67%
Payments to Acquire Property, Plant, and Equipment 134M USD +71.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 544M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid 1.03B USD +6.69%
Property, Plant and Equipment, Gross 6.12B USD +5.15%
Operating Lease, Liability, Current 185M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 217M USD +8.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -19.5M USD -172%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 166M USD +12.3%
Deferred Tax Assets, Operating Loss Carryforwards 224M USD -9.28%
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 32.2M USD +7.69%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 256M USD +16.7%
Depreciation, Depletion and Amortization 155M USD +8.73%
Deferred Tax Assets, Net of Valuation Allowance 713M USD +10.5%
Interest Expense 208M USD +4.36%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%